Don’t Let Stock Prices Fool You: KalVista Pharmaceuticals, Inc. (KALV), Exelon Corporation (EXC) – Post Analyst

This post was originally published on this site

Don’t Let Stock Prices Fool You: KalVista Pharmaceuticals, Inc. (KALV), Exelon Corporation (EXC)  Post Analyst

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) has a price-to-sales ratio of 22.84, well above its Biotechnology competitors. For the industry, the average P/S …

This post was originally published on *this site*